CAH: Emerging From Consolidation With Promise

Cardinal Health (NYSE: $CAH) experienced a commendable upward momentum last year until June when it encountered a sell-off leading into a consolidation phase. The current technical analyses hint at the termination of this consolidation, aligning well with the prevailing positive news sentiment. As CAH positions itself for a potential upward trajectory, investors and traders should exercise caution and consider a stop at the $86 mark to mitigate risks, acknowledging that market dynamics can shift and potentially impact the stock adversely.

Positive News Sentiment

Visit quantsync.substack.com for more setups